8-K

Company

Cartesian Therapeutics, Inc.

Filed

April 22, 2024

Period of Report

April 19, 2024

Accession Number

0001453687-24-000072

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →